Johnson & Johnson ordered to pay US$4.7bn in damages to women in talc cancer case

July 13, 2018
Johnson & Johnson (NYSE:JNJ) has been ordered to pay US$4.7bn to 22 women who claim the company’s talc products contain asbestos that caused them to develop ovarian cancer. Following a six-week trial at a court in the US state of Missouri, the jury in the ruled in favour of the women who were awarded US$500mln in compensation...
Advertisement

Related Videos


Time -   ▶  00:56



Reuters Studio -   ▶  01:09



Wochit News -   ▶  00:39



Bloomberg Global Business -   ▶  03:19



Wibbitz Studio -   ▶  01:17



Newsy Studio -   ▶  00:42



Buzz60 -   ▶  00:59



Wochit News -   ▶  00:32


Recent related news

A Missouri jury on Thursday ordered Johnson & Johnson to pay a record $4.69 billion to 22 women who alleged the company's talc-based products, including its baby...
1 week ago • Reuters

A St. Louis jury Thursday awarded $550 million in compensatory damages to 22 women who said Johnson & Johnson (NYSE: JNJ) talcum powder cased their ovarian...
1 week ago • bizjournals

Johnson & Johnson says it will "pursue all available appellate remedies" to reverse a St. Louis court verdict that awarded $4.7 billion to women who alleged that...
5 days ago • bizjournals

Interpace Diagnostics Group (NASDAQ:IDXG) has expanded the application of its pathology test PancraGEN beyond its use to see whether pancreatic cysts are...
2 days ago • Proactive Investors

You might like